hrinker_NN -LRB-_-LRB- ``_`` GPS_NNP ''_'' -RRB-_-RRB- and_CC Multi-Item_NNP Gamma_NNP Poisson_NNP Shrinker_NNP -LRB-_-LRB- ``_`` MGPS_NNP ''_'' -RRB-_-RRB- techniques_NNS to_TO FDA_NNP 's_POS combined_JJ SRS_NN and_CC AERS_NN databases_NNS and_CC to_TO validate_VB results_NNS retrospectively_RB against_IN known_JJ drug-induced_JJ adverse_JJ reactions_NNS =_JJ -_: =[_NN 1,2,3,4_CD -RRB-_-RRB- -_: =_SYM -_: ._.
Independent_JJ ,_, parallel_JJ efforts_NNS have_VBP proceeded_VBN at_IN the_DT UK_NNP Medicines_NNP Control_NNP Agency_NNP -LRB-_-LRB- MCA_NNP -RRB-_-RRB- where_WRB Dr._NNP Stephen_NNP Evans_NNP has_VBZ explored_VBN the_DT use_NN of_IN proportional_JJ reporting_NN ratios_NNS -LRB-_-LRB- PRR_NN 's_POS -RRB-_-RRB- -LRB-_-LRB- 5_CD -RRB-_-RRB- and_CC at_IN the_DT Uppsala_NNP Moni_NNP
